Health & Biotech ETFs
Most of these ETFs invest in companies involved in the healthcare and biotechnology industries. These ETFs can also feature healthcare providers, healthcare services, medical devices & equipment, and pharmaceuticals. While some of the category ETFs are focused primarily on growth from Biotech investing, the exposure to the category is ideal for moderate investors that can absorb whatever risk comes with this investing style while knowing there is the consistent revenue exposure to the healthcare industry in a good portion of these ETFs as well.
A
Category Grade
This category ranks #12 out of 65 ETF categories.
A
Strong Buy
Avg. SMART Grade
The average cap-weighted SMART Grade for ETFs in this category is A (Strong Buy).
| Fund Symbol/Name | Last | Open | High | Low | 52-Wk Hi | 52-Wk Lo | Day Chg | YTD Chg | 12-Mo Chg | AUM | Exp. Ratio | SMART Grade |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IHI iShares U.S. Medical Devices ETF |
222.41 | 222.68 | 223.00 | 222.17 | 223.88 | 165.30 | +0.19 (0.09%) |
28.20% | 33.64% | 2.69B | 0.44% |
A Strong Buy |
| FBT First Trust Amex Biotech Index Fund |
153.43 | 155.01 | 155.01 | 153.08 | 157.87 | 117.85 | -0.97 (-0.63%) |
23.17% | 24.99% | 2.16B | 0.56% |
A Strong Buy |
| IYH iShares U.S. Healthcare ETF |
201.55 | 201.85 | 202.55 | 201.30 | 202.55 | 166.89 | +0.26 (0.13%) |
16.00% | 17.26% | 2.12B | 0.44% |
A Strong Buy |
| IXJ iShares Global Healthcare ETF |
62.63 | 62.47 | 62.68 | 62.36 | 62.69 | 53.82 | +0.06 (0.10%) |
11.32% | 11.72% | 1.88B | 0.48% |
A Strong Buy |
| FHLC Fidelity MSCI Health Care Index ETF |
46.35 | 46.54 | 46.54 | 46.32 | 46.54 | 38.45 | -0.11 (-0.24%) |
16.28% | 17.76% | 1.31B | 0.08% |
A Strong Buy |
| FXH First Trust Health Care AlphaDEX |
82.92 | 83.22 | 83.27 | 82.92 | 83.96 | 65.80 | -0.17 (-0.20%) |
18.80% | 23.93% | 1.14B | 0.62% |
A Strong Buy |
| IHF iShares U.S. Health Care Providers ETF |
197.87 | 198.04 | 198.56 | 197.70 | 198.56 | 139.65 | +0.03 (0.02%) |
26.25% | 36.85% | 799.04M | 0.44% |
A Strong Buy |
| RYH Invesco S&P 500 Equal Weight Health Care ETF |
203.13 | 203.23 | 203.44 | 203.13 | 203.44 | 172.47 | +0.12 (0.06%) |
13.19% | 16.57% | 663.48M | 0.40% |
A Strong Buy |
| PJP Invesco Dynamic Pharmaceuticals ETF |
73.02 | 73.49 | 73.52 | 73.02 | 74.29 | 59.82 | -0.39 (-0.53%) |
13.89% | 12.42% | 578.12M | 0.56% |
A Strong Buy |
| BBH VanEck Vectors Biotech ETF |
132.32 | 133.30 | 133.55 | 132.00 | 136.76 | 111.36 | -0.61 (-0.46%) |
6.20% | -0.98% | 459.13M | 0.35% |
A Strong Buy |
| IHE iShares U.S. Pharmaceutical ETF |
169.20 | 169.83 | 170.26 | 169.15 | 170.26 | 139.28 | -0.28 (-0.17%) |
9.99% | 8.36% | 425.42M | 0.44% |
A Strong Buy |
| PPH VanEck Vectors Pharmaceutical ETF |
64.37 | 64.58 | 64.61 | 64.33 | 64.65 | 54.44 | -0.12 (-0.19%) |
9.29% | 11.97% | 284.99M | 0.35% |
A Strong Buy |
| PBE Invesco Dynamic Biotech & Genome ETF |
58.03 | 58.59 | 58.70 | 57.88 | 60.49 | 43.08 | -0.44 (-0.75%) |
23.05% | 17.42% | 282.88M | 0.58% |
A Strong Buy |
| SBIO ALPS Medical Breakthroughs ETF |
37.47 | 37.97 | 37.97 | 37.41 | 39.50 | 29.15 | -0.45 (-1.19%) |
14.27% | 20.02% | 262.19M | 0.50% |
A Strong Buy |
| PTH Invesco DWA Healthcare Momentum ETF |
95.87 | 96.27 | 96.82 | 95.68 | 98.66 | 64.71 | -0.68 (-0.70%) |
33.02% | 45.57% | 258.39M | 0.60% |
A Strong Buy |
| JHMH John Hancock Multifactor Healthcare ETF |
35.73 | 35.69 | 35.74 | 35.66 | 35.74 | 29.91 | +0.06 (0.17%) |
14.74% | 17.96% | 60.24M | 0.50% |
A Strong Buy |
| SLIM The Obesity ETF |
37.86 | 38.10 | 38.10 | 37.86 | 40.01 | 27.34 | +0.10 (0.26%) |
22.41% | 33.50% | 11.00M | 0.50% |
A Strong Buy |
| FTXH First Trust Nasdaq Pharmaceuticals ETF |
23.42 | 23.39 | 23.49 | 23.39 | 23.94 | 19.28 | -0.03 (-0.13%) |
9.83% | 17.07% | 5.84M | 0.60% |
A Strong Buy |
| IBB iShares Nasdaq Biotechnology Index Fund |
118.55 | 119.67 | 119.93 | 118.27 | 122.53 | 100.22 | -0.74 (-0.62%) |
11.03% | 7.36% | N/A | N/A |
A Strong Buy |
| PSCH Invesco S&P SmallCap Health Care ETF |
140.34 | 142.23 | 142.23 | 140.12 | 145.25 | 88.83 | -1.27 (-0.90%) |
42.45% | 57.78% | N/A | N/A |
A Strong Buy |
| VHT Vanguard Health Care ETF - DNQ |
179.14 | 179.53 | 179.81 | 179.14 | 179.81 | 148.31 | -0.06 (-0.03%) |
16.50% | 17.70% | N/A | N/A |
A Strong Buy |
| XBI SPDR Series Trust SPDR S&P Biotech ETF |
95.54 | 97.21 | 97.41 | 95.31 | 101.55 | 78.46 | -1.62 (-1.67%) |
12.64% | 12.94% | N/A | N/A |
A Strong Buy |
| XHE SPDR S&P Health Care Equipment |
86.87 | 87.01 | 87.48 | 86.78 | 89.07 | 61.75 | -0.13 (-0.15%) |
34.89% | 39.97% | N/A | N/A |
A Strong Buy |
| XHS SPDR S&P Health Care Services ETF |
75.82 | 75.69 | 76.18 | 75.69 | 76.34 | 56.18 | -0.08 (-0.11%) |
23.15% | 28.45% | N/A | N/A |
A Strong Buy |
| XLV SPDR Select Sector Fund - Health Care |
94.27 | 94.39 | 94.48 | 94.07 | 94.57 | 78.74 | -0.24 (-0.25%) |
14.42% | 15.56% | N/A | N/A |
A Strong Buy |
| XPH SPDR S&P Pharmaceuticals ETF |
48.69 | 48.95 | 48.98 | 48.62 | 49.97 | 38.71 | -0.16 (-0.33%) |
11.98% | 14.94% | N/A | N/A |
A Strong Buy |
| BBP Virtus LifeSci Biotech Products ETF |
44.21 | 44.35 | 44.35 | 44.21 | 46.80 | 37.33 | -0.47 (-1.05%) |
9.00% | 8.44% | N/A | N/A |
A Strong Buy |
| ARKG ARK Genomic Revolution Multi-Sector ETF |
32.71 | 33.76 | 33.83 | 32.64 | 34.69 | 23.41 | -0.95 (-2.82%) |
33.56% | 27.03% | 252.48M | 0.75% |
B Buy |
| BTEC Principal Healthcare Innovators Index ETF |
36.68 | 37.34 | 37.34 | 36.68 | 39.21 | 28.87 | -0.22 (-0.60%) |
16.63% | 20.42% | 54.72M | 0.42% |
B Buy |
| BBC Virtus LifeSci Biotech Clinical Trials ETF |
34.45 | 34.76 | 34.76 | 34.45 | 36.25 | 25.88 | -0.63 (-1.80%) |
21.17% | 20.03% | N/A | N/A |
B Buy |
| CNCR Loncar Cancer Immunotherapy ETF |
24.77 | 25.00 | 25.00 | 24.70 | 32.32 | 23.13 | -0.19 (-0.76%) |
4.16% | -4.80% | N/A | N/A |
C Neutral |
| IEHS iShares Evolved U.S. Healthcare Staples ETF |
29.45 | 29.45 | 29.51 | 29.45 | 29.52 | 24.00 | -0.01 (-0.03%) |
20.35% | 20.35% | 5.65M | 0.18% |
NR Not Rated |
| IEIH iShares Evolved U.S. Innovative Healthcare ETF |
27.14 | 27.18 | 27.18 | 27.14 | 27.86 | 22.98 | -0.03 (-0.11%) |
12.20% | 12.20% | 5.28M | 0.18% |
NR Not Rated |
| GNRX VanEck Vectors Generic Drugs ETF |
25.45 | 25.55 | 25.55 | 25.45 | 26.68 | 22.04 | +0.20 (0.79%) |
4.00% | 12.76% | N/A | N/A |
NR Not Rated |
Get Free Updates
Most Popular Articles
Time To Consider Some Anti-U.S. Trades Like Gold?
Moving Up in Credit Quality for Better Durability
Overbought Signals Emerge For The S&P 500